We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Sponsor content
356 result(s) found, displaying 91 to 100
-
Australian public assessment report (AusPar)Keytruda (pembrolizumab) for the treatment of patients with Bacillus Calmette-Guerin (BCG)-unresponsive, high-risk, non-muscle invasive bladder cancer (NMIBC) with carcinoma in-situ (CIS) with or without papillary tumours who are ineligible for or have elected not to undergo cystectomy.
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Australian public assessment report (AusPar)AusPAR for Keytruda (pembrolizumab) for the treatment of Oesophageal Cancer
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LAGEVRIO molnupiravir 200 mg capsules bottle.
-
Australian public assessment report (AusPar)AusPAR for Keytruda (pembrolizumab) for the treatment of patients with Bacillus Calmette-Guerin (BCG)-unresponsive, high-risk, non-muscle invasive bladder cancer (NMIBC) with carcinoma in-situ (CIS) with or without papillary tumours who are ineligible for or have elected not to undergo cystectomy.
-
Australian public assessment report (AusPar)AusPAR for Keytruda (pembrolizumab) for the treatment relapsed or refractory classical Hodgkin Lymphoma
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VAXNEUVANCE Pneumococcal 15-valent Conjugate Vaccine [CRM197 Protein], adsorbed 0.5 mL Suspension for intramuscular injection, Pre-filled syringe.
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Prescription medicine registrationActive ingredients: HPV Type 11 L1 Protein, HPV Type 16 L1 Protein, HPV Type 18 L1 Protein, HPV Type 31 L1 Protein, HPV Type 33 L1 Protein, HPV Type 45 L1 Protein, HPV Type 52 L1 Protein, HPV Type 58 L1 Protein, HPV Type 6 L1 Protein.